Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells

Journal of Cell Biology

Volumn 101, Issue 3, 1985, Pages 1059-1070

  Majack, Richard A ^a   Cook, Susan Coates ^a   Bornstein, Paul ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; INSULIN; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN;

CELL GROWTH; DOSE RESPONSE; DRUG COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG SYNTHESIS; GREAT BLOOD VESSEL; IN VITRO STUDY; METHIONINE S 35; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SYNTHESIS; SMOOTH MUSCLE FIBER;

ANIMAL; CELL MOVEMENT; CELLS, CULTURED; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HEPARIN; KINETICS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOSPONDINS;

EID: 0022250251     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.101.3.1059     Document Type: Article

References (81)

1. Baenziger, N. L., G. N. Brodie, and P. W. Majerus. 1972. Isolation and properties of a thrombin-sensitive protein of human platelets. J.Biol. Chem. 248: 2723-2731.
2. Bitterman, P. B., S. I. Rennard, S. Adelberg, and R. G. Crystal. 1983. Role of fibronectin as a growth factor for fibroblasts. J.Cell Biol. 97: 1925-1932.
3. Castellot, J. J., M. L. Addonizio, R. D. Rosenberg, and M. J. Kamovsky. 1981. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J.Cell Biol. 90: 372-379.
4. Castellot, J. J., L. V. Favreau, M. J. Kamovsky. and R. D. Rosenberg. 1982. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. J.Biol. Chem. 257: 11256-11260.
5. Clemmons, D. R. 1984. Interaction ofcirculating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication. J. Cell. Physiol. 121: 425-430.
6. Clowes, A. W., and M. J. Kamovsky. 1977. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (Lond.) 265: 625-626.
7. Clowes, A. W" M. M. Clowes, A. M. Gown, and T. N. Wight. 1984. Localization of proteoheparan sulfate in rat aorta. Histochemistry. 80: 379-384.
8. Cochran, D. L., J. J. Castellot. and M. J. Kamovsky. 1983. Effects of heparin on vascular smooth muscle metabolism. J. Cell Biol. 97(pt. 2): 395a. (Abstr.)
9. Cochran, B. H., A. C. Reffel.andC. D.Stiles. 1983. Molecular cloning ofgene sequences regulated by platelet-derived growth factor. Cell. 33: 939-947.
10. Cochran, B. H., J. Zullo. I. M. Verma, and C. D. Stiles. 1984. Expression of the c-fos gene and of a fos-related gene is stimulated by platelet-derived growth factor. Science (Wash. DC). 226: 1080-1082.
11. Coligan, J. E., and H. S. Slayter. 1984. Structure of thrombospondin. J.Biol. Chem. 259: 3944-3948.
12. Curran, T., A. D. Miller. L. Zokas., and I. M. Verma. 1984. Viral and cellular proteins: a comparative analysis. Cell. 36: 259-268.
13. Davies, P. F., and R. Ross. 1978. Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J. Cell Biol. 79: 663-671.
14. DiCorleto, P. E., and D. F. Bowen-Pope. 1983. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc. Nall. Acad. Sci. USA. 80: 1919-1923.
15. Dietrich, C. P., H. B. Nader, and A. H. Straus. 1983. Structural differences of heparan sulfates according to the tissue and species of origin. Biochem. Biophys. Res. Commun. 111: 865-871.
16. Dixit, V. M., G. A. Grant. W. A. Frazier, and S. A. Santoro. 1984. Isolation of the fibrinogen-binding region of platelet thrombosjwndin. Biochem. Biophys. Res. Commun. 119: 1075-1081.
17. Dixit, V. M., G. A. Grant, S. A. Santoro, and W. A. Frazier. 1984. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombosp>ondin. J. Biol. Chem. 259: 10100-10105.
18. Donner, P., I. Greiser-Wilke, and K. Moelling. 1982. Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature (Land.) 296: 262-266.
19. Fox, P. L., and P. E. DiCorleto. 1984. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. J. Cell. Physiol. 121: 298-308.
20. Fritze, L. M. S., and R. D. Rosenberg. 1983. Bovine aortic smooth muscle cells produce an inhibitor of smooth muscle cell growth in vitro. J. Cell Biol. 97(No. 5, pt. 2): 90a. (Abstr.)
21. Gamse, G., H. G. Fromme, and H. Kresse. 1978. Metabolism of sulfated glycosamino-glycans in cultured endothelial cells and smooth muscle cells from bovine aorta. Biochim. Biophys. Acta. 544: 514-518.
22. Gospodarowicz, D., and C. R. 111. 1980. Ek plasma and serum have different abilities to promote cell growth? Proc. Natl. Acad. Sci. USA 77: 2726-2730.
23. Grotendorst, G. R., T, Chang, H. E. J. Seppa. H. K. Kleinman, and G. R. Martin. 1983. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell. Plmiol. 113: 261-266.
24. Guyton, J. R., R. D. Rosenberg, A. W. Clowes, and M. J. Kamovsky. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. I. In vivo studies with anticoagulant and non-anticoagulant heparin. Circ. Res. 46: 625-634.
25. Hata, R., H. Hori, Y. Nagai, S. Tanaka, M. Kondo, M. Hiramatsu, N. Utsum, and M. Kumegawa. 1984. Selective inhibition of type I collagen synthesis in osteoblastic cells by epidermal growth factor. Endocrinology. 115: 867-876.
26. Hatcher, V. B., G. Tsien. M. S. Oberman. and P. G. Burk. 180. Inhibition of cell proliferation and protease activity by cartilage factors and heparin. J. Supramol. Struct. 14: 33-46.
27. Hendrickson, S. L., and C. D. Scher. 1983. Platelet-derived growth factor-modulated translatable mRNAs. Moi Cell. Biol. 3: 1478-1487.
28. Hoover, R. L., R. D. Rosenberg. W. Haering, and M. J. Kamovsky. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ. Res. 47: 578-583.
29. Jaffe, E. A., L. L. K. Leung, R. L. Nachman. R. I. Levin, and D. F. Mosher. 1982. Thrombospondin is the endogenous lectin of human platelets. Nature (Lond.) 295: 246-248.
30. Jaffe, E. A., J. T. Ruggiero, L. L. K. Leung, M. J. Doyle, P. J. McKeown-Longo, and D. F. Mosher. 1983. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl Acad. Sci. USA 80: 998-1002.
31. Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-mv’c gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 35: 603-610.
32. Kjellen, L., A. Oldberg, and M. Hook. 1980. Cell surface heparan sulfate. J. Biol Chem. 255: 10407-10413.
33. Kleinman, H. K., R. J. Klebe, and G. R. Martin. 1981. Role of collagenous matrices in the adhesion and growth of cells. J.Cell Biol 88: 473-485.
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227: 680-685.
35. Lahav, J., J. Lawler, and M. A. Gimbrone. 1984. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding. Eur. J. Biochem. 145: 151-156.
36. Lahav, J., M. A. Schwartz, and R. O. Hynes. 1982. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen. Cell. 31: 253-262.
37. Lawler, J. W., F. C. Chao, and C. M. Cohen. 1982. Evidence for calcium-sensitive structure in platelet thrombospondin. J. Biol. Chem. 257: 12257-12265.
38. Lawler, J. W., H. S. Slayter, and J. E. Coligan. 1978. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J.Biol. Chem. 253: 8609-8616.
39. Lembach, K. J. 1976. Induction of human fibroblast proliferation by epidermal growth factor (EGF): enhancement by an EGF-binding arginine esterase and by ascorbate. Proc. Natl .4cad. Sci. USA 73: 183-187.
40. Leung, L. L. K. 1984. Role of thrombospondin in platelet aggregation. J.Clin. Invest. 74: 1764-1772.
41. Libby, P., and K. V. O’Brien. 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J.Cell. Physiol. 115: 217-223.
42. Majack, R. A., and P. Bomstein. 1984. Heparin and related glycosaminoglycans regulate the secretory phenotype of vascular smooth muscle cells. J. Cell Biol. 99: 1688-1695.
43. Majack, R. A., and P. Bomstein. 1985. Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an A/r 60.000 collagen. J. Celt Biol. 100: 613-619.
44. Majack, R. A., and P. Bomstein. 1985. Regulation of collagen biosynthesis: Heparin alters the biosynthetic phenotyp>e of vascular smooth muscle cells. Ann. NY Acad. Sci. In press.
45. Majack, R. A., and P. Bomstein. 1985. Biosynthesis and modulation of extracellular matrix components by cultured vascular smooth muscle cells. In The Vascular Smooth Muscle Cell in Culture. J. H. Chamley-Campbell and G. R. Campbell, editors. CRC Press, Boca Raton, FL. In press.
46. Majack, R. A., and A. W. Clowes. 1984. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol 118: 253-256.
47. Majack, R. A., S. C. Cook, and P. Bomstein. 1985. Thrombospondin, a PDGF-inducible protein, may play a role in the regulation of vascular smooth muscle cell migration by glycosaminoglycans. Fed. Proc. 44: 738.(Abstr.)
48. Marcum, J. A., and R. D. Rosenberg. 1984. Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 23: 1130-1737.
49. Margossian, S. S., J. W. Lawler, and H. S. Slayter. 1981. Physical characterization of platelet thrombosixmdin. J.Biol. Chem. 256: 7495-7500.
50. McKeown-Longo, P. J., R. Hanning, and D. F. Mosher. 1984. Binding and degradation of platelet thrombospondin by cultured fibroblasts. J.Cell Biol 98: 22-28.
51. McPherson, J., H. Se, and P. Bomstein. 1981. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J. Biol Chem. 256: 11330-11336.
52. Mosher, D. F., M. F. Doyle, and E. A. Jaffe. 1982. Synthesis and secretion of thrombospondin by cultured endothelial cells. J. Cell Biol. 93: 343-348.
53. Mumby, S. M., G. J. Raugi, and P. Bomstein. 1984. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J. Cell Biol. 98: 646-652.
54. Mumby, S. M., D. Abbott-Brown, G. J. Raugi, and P. Bomstein. 1984. Regulation of thrombosixmdin secretion by cells in culture. J. Cell. Physiol. 120: 280-288.
55. Narayanan, A. S., and R. C. Page. 1983, Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J. Biol. Chem. 258: 11694-11699.
56. Nilsen-Hamilton, M., J. M. Shapiro, S. L. Massoglia, and R. T. Hamilton. 1980. Selective stimulation by mitogens of incorporation of [SJmethionine into a family of proteins released into the medium by 3T3 cells. Cell. 20: 19-28.
57. Nilsson, J., T. Ksiazek, C.-H. Heldin, and J. Thyberg. 1983. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Exp. Cell Res. 145: 231-237.
58. Nilsson, J., T. Ksiazek, J. Thyberg, and A. Wateson. 1983. Cell surface components and growth regulation in cultivated arterial smooth muscle cells. J.Celt Sci. 64: 107-121.
59. Olashaw, N. E., and W. J. Pledger. 1983. Association of platelet-derived growth factor-induced protein with nuclear material. Nature (Lond.). 306: 272-274.
60. Oldberg, A., C.-H. Heldin, A. Wasteson, C. Busch, and M. Hook. 1980. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides. Biochemistry. 19: 5755-5762.
61. Oohira, A., T. N. Wight, and P. Bomstein. 1983. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J. Biol Chem. 258: 2014-2021.
62. Oosta, G. M., L. V. Favreau, D. L. Beeler, and R. D. Rosenbei. 1982. Purification and properties of human platelet heparatinase. J.Biol. Chem. 257: 11249-11255.
63. Pledger, W. J., C. A. Hart, K. L. Locatell, and C. D. Scher. 1981. Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc. Natl. Acad. Sci. USA. 78: 4358-4362.
64. Raines, E. W., and R. Ross. 1982. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J.Biol. Chem. 257: 5154-5160.
65. Raugi, G. J., J. M. Mumby, D. Abbott-Brown, and P. Bomstein. 1982. Thrombospondin: synthesis and secretion by cells in culture. J.Cell. Biol. 95: 351-354.
66. Raugi, G. J., J. M. Mumby, C. A. Ready, and P. Bomstein. 1984. Location and partial characterization of the heparin-binding fragment of platelet thrombospondin. Throm. Res. 36: 165-175.
67. Ross, R., and J. A. Glomset. 1976. The pathogenesis of atherosclerosis (first of two parts). N. Engl. J. Med. 295: 369-377.
68. Ross, R., and J. A. Glomset. 1976. The pathogenesis of atherosclerosis (second of two parts). N. Engl. J. Med. 295: 420-425.
69. Ross, R., and A. Vogel. 1978. The platelet-derived growth factor. Cell. 14: 203-210.
70. Ross, R., A. Vogel, P. Davies, E. Raines, B. Kariya, M. J. Rivest. C. Gustafson, and J. Glomset. 1979. The platelet-derived growth factor and plasma control cell proliferation. In Hormones and (Tell Culture. Book A. G. Sato and R. Ross, editors. Cold Spring Harbor Press, Cold Spring Harbor, NY. 3-16.
71. Sage, H., P. Pritzl, and P. Bomstein. 1981. Secretory phenotypes of endothelial cells in culture: a comparison of aortic, venous, capillary, and comeal endothelium. Arteriosclerosis. 1: 427-442.
72. Sage, H., F. H. Farin, G. E. Striker, and A. B. Fisher. 1983. Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochem-isiry. 22: 2148-2155.
73. Salomon, D. S., L. A. Liotta, and W. R. Kidwell. 1981. Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc. Nall. Acad. Sci. USA. 78: 382-386.
74. Scher, C. D., R. L. Dick. A. P. Whipple, and K. L. Locatell. 1983. Identification of a BALB/C-3T3 cell protein modulated by platelet-derived growth factor. Mol. Cell. Biol. 3: 70-81.
75. Seifert, R. A., S. M. Schwartz, and D. F. Bowen-Pope. 1984. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature (Lond.). 311: 669-671.
76. Steinmann, B. U., S. Abe. and G. R. Martin. 1982. Modulation of type I and III collagen production in normal and mutant human skin fibroblasts by cell density, prostaglandin E2 and epidermal grovrth factor. Collagen Rel. Res. 2: 185-195.
77. Stiles, C. D., W. J, Pledger. R. W. Tucker, R. G. Martin, and C. D. Scher. 1980. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors. J. Supramol. Struci. 13: 489-499.
78. Tseng, S. C. G., N. Savion, R. Stern, and D. Gospodarowicz, 1982. Fibroblast growth factor modulates synthesis of collagen in cultured vascular endothelial cells. Eur. J. Biochem. 122: 355-360.
79. Walker, L. N., D. F. Bowen-Pope, and M. A. Reidy. 1984, Secretion of platelet-derived growth factor (PDGF)-like activity by smooth muscle cells is induced as a response to injury. J. Cell Biol. 99: 416a. (Abstr.)
80. Wight, T. N., and V. C. Hascall. 1983. Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture. J. Cell Biol. 96: 167-176.
81. Wight, T. N., G. J. Raugi, S. M. Mumby and P. Bomstein. 1985. Light microscopic immunolocation of thrombospondin in human tissues. J. Hisiochem. Cvtochem. 33: 295-302.